Knowledge Transfer Statement: This article discusses the proceedings of the conference organized by the Task Force on Design and Analysis in Oral Health Research on the understanding of the translational evidence on the etiology and pathogenesis of medication-related osteonecrosis of the jaw as well as the clinical protocols on patient management.
AghalooTHazbounRTetradisS.2015. Pathophysiology of osteonecrosis of the jaws. Oral Maxillofac Surg Clin North Am. 27(4):489–496.
2.
de MolonRSCheongSBezouglaiaODrySMPirihFCirelliJAAghalooTLTetradisS.2014. Spontaneous osteonecrosis of the jaws in the maxilla of mice on antiresorptive treatment: a novel ONJ mouse model. Bone. 68:11–19.
3.
KangBCheongSChaichanasakulTBezouglaiaOAttiEDrySMPirihFQAghalooTLTetradisS.2013. Periapical disease and bisphosphonates induce osteonecrosis of the jaws in mice. J Bone Miner Res. 28(7):1631–1640.
4.
KhanAAMorrisonAHanleyDAFelsenbergDMcCauleyLKO’RyanFReidIRRuggieroSLTaguchiATetradisSet al. 2015. Diagnosis and management of osteonecrosis of the jaw: a systematic review and international consensus. J Bone Miner Res. 30(1):3–23.
5.
PushalkarSLiXKuragoZRamanathapuramLVMatsumuraSFleisherKEGlickmanRYanWLiYSaxenaD.2014. Oral microbiota and host innate immune response in bisphosphonate-related osteonecrosis of the jaw. Int J Oral Sci. 6(4):219–226.
6.
RuggieroSLDodsonTBFantasiaJGooddayRAghalooTMehrotraBO’RyanF; American Association of Oral and Maxillofacial Surgeons. 2014. American Association of Oral and Maxillofacial Surgeons position paper on medication-related osteonecrosis of the jaw—2014 update. J Oral Maxillofac Surg. 72(10):1938–1956. Erratum in: J Oral Maxillofac Surg. 2015;73(9):1879. J Oral Maxillofac Surg. 2015;73(7):1440.
